Drug licences of 18 pharma firms cancelled for manufacturing poor quality meds

Summary by Live Mint

Decision came following inspection by state and central regulators

Published 2 months ago

News Articles

More
Filters

All

Left

Center

Right

Times of India

Drug licences of 18 pharma firms cancelled for manufacturing spurious medicines: DCGI

Licences of as many as 18 pharma companies were cancelled on Tuesday for manufacturing spurious medicines after an inspection by the Drugs Controller General of India (DCGI).

2 months ago·Mumbai, India

Read Full Article

The Hindu

Licences of 18 pharma firms cancelled for manufacturing spurious drugs

In a major crackdown, license of 18 pharma companies have been cancelled for manufacturing of spurious medicines

2 months ago·India

Read Full Article

Indian Express

Licences of 18 pharma firms cancelled for manufacturing spurious drugs, says report

"Licences of 18 pharma companies have been cancelled for manufacturing spurious and adulterated drugs and for violating GMP (good manufacturing practice).... Besides, 26 firms have been given show-cause notices," an official source said.

2 months ago·India

Read Full Article

ABP News

Licences Of 18 Pharma Firms Cancelled For Manufacturing Spurious Drugs: Report

The government of India cancelled licenses of eighteen pharmaceutical companies for manufacturing spurious medicines following an inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 States, news agency ANI reported citing official sources on Tuesday. As per the report, a huge crackdown is underway on pharma companies across the country related to the manufacturing of spurious medicines. "Action on 70 companies i…

2 months ago·India

Read Full Article

Live Mint

Drug licences of 18 pharma firms cancelled for manufacturing poor quality meds

Decision came following inspection by state and central regulators

2 months ago·New Delhi, India

Read Full Article

DNA India

Major pharma crackdown: Licences of 18 firms cancelled for manufacturing spurious drugs

The crackdown comes in the wake of recent overseas incidents that have raised questions over the quality of drugs being produced by India-based manufacturers.

2 months ago·New Delhi, India

Read Full Article